Newer biomarkers, for example, leucine-rich alpha-2 glycoprotein (LRG), whose blood level was shown to correlate with disease activity in UC or microRNA molecules that are differentially expressed in blood or tissue, are under investigation for use in the assessment of IBD disease activity [40]. Here, LRG1 is linked to inflammatory bowel disease.